Monday, October 10, 2022 Daily Archives

Sartorius eyes Korea opportunities through $265m investment

by

Sartorius has signed a land purchase agreement with the Incheon Free Economic Zone Authority (IFEZ) as it preps to bring its biomanufacturing portfolio to the robust Korean market. While Sartorius has run a sales and service office in South Korea for more than 30 years, the bioprocess vendor announced its intention to invest significantly in manufacturing operations in the region last November, pledging €270 million ($265 million) through the end of 2024. Now building is set to commence, following the…

October 10, 2022

Intravacc bags two intranasal vaccine deals in one week

by

A $14.6 million contract for its jointly developed gonorrhea vaccine and a partnership with CEPI to advance coronavirus vaccines make a busy week for Intravacc. Dutch firm, Intravacc, and microparticulate immune therapeutics firm Therapyxpartnered in August 2020 to develop NGoXIM, a prophylactic vaccine that treats gonorrhea. This week, the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the firms a contract with base and options that could potentially total…

October 10, 2022

Novavax to pay Fujifilm up to $185m after axing vaccine contract

by

CDMO Fujifilm Diosynth Corporation will receive up to $185 million after Novavax cancelled a Commercial Supply Agreement (CSA) relating to its COVID-19 vaccine. According to an SEC filing, the CSA dated August 20, 2021 and a Master Services Agreement (MSA) dated June 30, 2020 between Novavax and Fujifilm have been terminated. As such, Novavax will now pay the contract development and manufacturing organization (CDMO) up to $185 million in a settlement payment. This comprises of $48 million paid in September,…

October 10, 2022